Matsui e-clinic

Akashi, Hyōgo 673-0891

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer Disease

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling